Symptom-centric view
Application site pain
Substances reporting Application site pain disproportionately — ranked by ROR.
showing 1 of 1
| Substance ↓ | ROR [95% CI] | Reports | Category | Label |
|---|---|---|---|---|
minoxidil Rogaine · Loniten | 32.9 [31.2–34.8] | 1,394 | glp-1 | new |
ROR = reporting odds ratio vs. the full FAERS corpus. A signal is not a cause. Source: openFDA (FAERS).